Elanco Animal Health (ELAN) Other Working Capital Changes (2018 - 2026)
Elanco Animal Health (ELAN) posted Other Working Capital Changes of $21.0 million for Q1 2026, down 59.62% sequentially from $52.0 million in Q4 2025, and up 310.0% YoY from $5.1 million in Q1 2025.
Elanco Animal Health (ELAN) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Elanco Animal Health has reported Other Working Capital Changes for 10 years, with the latest figure at $21.0 million in Q1 2026.
- Quarterly Other Working Capital Changes rose 310.0% year-over-year to $21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.0 million (up 8.7% YoY) and the FY2025 annual result came in at -$6.0 million, down 300.0% from the prior year.
- Other Working Capital Changes retreated to $21.0 million in Q1 2026 per ELAN's latest filing, from $52.0 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $439.0 million in Q1 2023 and troughed at -$440.0 million in Q4 2023.
- A 5-year average of $20.4 million and a median of $1.0 million in 2022 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes jumped 1050.0% in 2023, then slumped 600.0% in 2024.
- Over 5 years, Other Working Capital Changes stood at -$2.0 million in 2022, then surged by 1050.0% to $19.0 million in 2023, then surged by 173.68% to $52.0 million in 2024, then changed by 0.0% to $52.0 million in 2025, then tumbled by 59.62% to $21.0 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $21.0 million, $52.0 million, and -$30.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.00 Mn |
| Jun 30, 2026 | -24.00 Mn |
| Jun 30, 2026 | -24.00 Mn |
| Mar 31, 2026 | 263.00 Mn |
| Mar 31, 2026 | 263.00 Mn |
| Mar 31, 2026 | 263.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Jun 30, 2025 | -52.00 Mn |
| Jun 30, 2025 | -52.00 Mn |
| Jun 30, 2025 | -52.00 Mn |
| Mar 31, 2025 | 237.00 Mn |
| Mar 31, 2025 | 237.00 Mn |
| Mar 31, 2025 | 237.00 Mn |
| Dec 31, 2024 | 82.00 Mn |
| Dec 31, 2024 | 82.00 Mn |